Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
Johnson and Johnson
Medtronic
Express Scripts

Last Updated: May 26, 2022

Investigational Drug Information for Tocotrienol


✉ Email this page to a colleague

« Back to Dashboard

What is the drug development status for Tocotrienol?

Tocotrienol is an investigational drug.

There have been 23 clinical trials for Tocotrienol. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2016.

The most common disease conditions in clinical trials are Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, and Pancreatic Neoplasms. The leading clinical trial sponsors are Vejle Hospital, Texas Tech University Health Sciences Center, and National Cancer Institute (NCI).

Recent Clinical Trials for Tocotrienol
TitleSponsorPhase
Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)Hovid BerhadPhase 2
Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)Monash University MalaysiaPhase 2
Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)Yuen Kah HayPhase 2

See all Tocotrienol clinical trials

Clinical Trial Summary for Tocotrienol

Top disease conditions for Tocotrienol
Top clinical trial sponsors for Tocotrienol

See all Tocotrienol clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Colorcon
Johnson and Johnson
Medtronic
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.